Abbott's Q1 MDx Sales Rise 5 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Abbott today reported 3 percent first quarter growth for its diagnostics business including a 5 percent increase in year-over-year molecular diagnostics sales.

The firm reported overall diagnostics dales of $1.12 billion for the three months ended March 31, up from $1.09 billion for Q1 2013. On an operational basis, its diagnostics sales were up 5 percent. It said that the diagnostics business was hit by a 2.5 percent negative effect from foreign exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: sequencing technique to uncover plant disease-resistance genes, and more.

In a Science Translational Medicine opinion piece, a Merck executive suggests that universities offer money-back guarantees on their research.

NantKwest's Patrick Soon-Shiong received some $148 million in compensation in 2015.

With sequencing moving toward applications, Illumina CEO Francis deSouza says his company has even more to offer, Fast Company reports.